Finance

Lists
KROS:NASDAQ
Keros Therapeutics Inc
9,36 US$
-0,95%
(-0,090) 1D
6 ნოე, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KROS...
Open
9,74 US$
High
9,98 US$
Low
9,26 US$
Mkt. cap
185,58 მლნ.
Avg. vol.
164,30 ათ.
Volume
0,00
52-wk high
22,55 US$
52-wk low
9,26 US$
EPS
-2,83 US$
Beta
1,13
Shares outstanding
19,62 მლნ.
No. of employees
87
Open
9,74 US$
High
9,98 US$
Low
9,26 US$
Mkt. cap
185,58 მლნ.
Avg. vol.
164,30 ათ.
Volume
0,00
52-wk high
22,55 US$
52-wk low
9,26 US$
EPS
-2,83 US$
Beta
1,13
Shares outstanding
19,62 მლნ.
No. of employees
87
News stories
From web sources and news partners
About Keros Therapeutics Inc
CEO-
Employees87
Founded2015
HeadquartersLexington, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitekerostx.com
Analyst ratings
Based on 3 analysts giving stock ratings to KROS in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for KROS in the last 3 months.
Highest
Current 9,36 US$
20,00 US$ (+113,68%)
Average
18,33 US$ (+95,83%)
Lowest
17,00 US$ (+81,62%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
20,00 US$
+113,7%
11/06/2026
Benjamin Burnett
Wells Fargo
Buy
Maintained
18,00 US$
+92,3%
09/02/2026
Jason Zemansky
Bank of America Securities
Hold
Reiterated
17,00 US$
+81,6%
08/11/2026
Yun Zhong
Wedbush
Hold
Maintained
16,00 US$
+70,9%
08/04/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
08/04/2026
Thomas Smith
Leerink Partners
Buy
Maintained
23,00 US$
+145,7%
08/04/2026
Nicholas Lorusso
TD Cowen
Hold
Reiterated
-
-
08/04/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
-
-
05/15/2026
Andreas Argyrides
Oppenheimer
Buy
Maintained
27,00 US$
+188,5%
03/09/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
30,00 US$
+220,5%
03/06/2026
Tiago Fauth
Raymond James
Buy
Maintained
20,00 US$
+113,7%
03/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
385,00 ათ.
367,00 ათ.
-
40,01 მლნ.
Cost of goods sold
17,81 მლნ.
16,10 მლნ.
22,33 მლნ.
-
Cost of revenue
17,81 მლნ.
16,10 მლნ.
22,33 მლნ.
-
Research and development expenses
-
-
-
20,49 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,74 მლნ.
10,15 მლნ.
8,61 მლნ.
6,70 მლნ.
Operating expense
11,74 მლნ.
10,15 მლნ.
8,61 მლნ.
27,19 მლნ.
Total operating expenses
29,56 მლნ.
26,24 მლნ.
30,94 მლნ.
27,19 მლნ.
Operating income
-29,17 მლნ.
-25,88 მლნ.
-30,94 მლნ.
12,82 მლნ.
Other non operating income
-539,00 ათ.
-
-60,00 ათ.
-168,00 ათ.
EBT including unusual items
-24,98 მლნ.
-23,71 მლნ.
-28,71 მლნ.
14,92 მლნ.
EBT excluding unusual items
-24,88 მლნ.
-23,71 მლნ.
-28,71 მლნ.
14,92 მლნ.
Income tax expense
-1,51 მლნ.
-
-
772,00 ათ.
Effective tax rate
6,06%
-
-
5,17%
Other operating expenses
-
-
-
-
Net income
-23,46 მლნ.
-23,71 მლნ.
-28,71 მლნ.
14,15 მლნ.
Net profit margin
-6 093,77%
-6 459,95%
-
35,37%
Earnings per share
-0,86
-1,21
-1,45
0,70
Interest and investment income
4,02 მლნ.
2,34 მლნ.
2,29 მლნ.
2,28 მლნ.
Interest expense
-
-
-
-
Net interest expenses
4,02 მლნ.
2,34 მლნ.
2,29 მლნ.
2,28 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-28,77 მლნ.
-25,47 მლნ.
-30,54 მლნ.
13,20 მლნ.
Gain or loss from assets sale
1,00 ათ.
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები